EcoDrugPlus

Ribosomal Protein L35

Ensembl ID : ENSOMYG00000045792
Gene Symbol: RPL35
1 Cross references
252 Possible Orthologues:

Ribosomal Protein L35

Ensembl ID : ENSOMYG00000055069
Gene Symbol: RPL35
1 Cross references
254 Possible Orthologues:

Ribosomal Protein L35

Ensembl ID : ENSOMYG00000042997
Gene Symbol: RPL35
2 Cross references
265 Possible Orthologues:

Ribosomal Protein L35a

Ensembl ID : ENSOMYG00000042152
Gene Symbol: RPL35A
1 Cross references
448 Possible Orthologues:

Ribosomal Protein L35a

Ensembl ID : ENSOMYG00000046038
Gene Symbol: RPL35A
1 Cross references
446 Possible Orthologues:

Ribosomal Protein L37

Ensembl ID : ENSOMYG00000037290
Gene Symbol: RPL37
1 Cross references
419 Possible Orthologues:

Ribosomal Protein L38

Ensembl ID : ENSOMYG00000038132
Gene Symbol: RPL38
2 Cross references
195 Possible Orthologues:

Ribosomal Protein L39

Ensembl ID : ENSOMYG00000046635
Gene Symbol: RPL39
1 Cross references
68 Possible Orthologues:

Ribosomal Protein L4

Ensembl ID : ENSOMYG00000015672
Gene Symbol: RPL4
1 Cross references
339 Possible Orthologues:

Ribosomal Protein L5

Ensembl ID : ENSOMYG00000015440
Gene Symbol: RPL5
1 Cross references
420 Possible Orthologues:

Ribosomal Protein L5

Ensembl ID : ENSOMYG00000015949
Gene Symbol: RPL5
2 Cross references
419 Possible Orthologues:

Ribosomal Protein L5

Ensembl ID : ENSOMYG00000041957
Gene Symbol: RPL5
1 Cross references
463 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).